| Literature DB >> 10657483 |
X Ni1, B C Lin, C Y Song, C H Wang.
Abstract
It has been well known that immune function is modulated by endogenous opioid peptides: beta-endorphin and enkephalins. However, the effect of dynorphin A on the immune function has not been well documented. In this study, we investigated dynorphin A in the regulation of mitogen-induced proliferation and and interleukin-2 (IL-2) production of rat splenocytes. The results showed that dynorphin A 1-13 as well as dynorphin A 1-17 enhanced concanavalin A-stimulated [(3)H] thymidine uptake 46-112% and IL-2 production in a dose-dependent fashion. These effects were reversed by naloxone and norBNI, a selective kappa-receptor antagonist. Dynorphin A reduced cyclic AMP contents in spenocytes in naloxone and norBNI reversible fashion. The data suggest that dynorphin A enhanced mitogen-stumulated lymphocyte proliferation and IL-2 production via kappa-opioid receptor and cAMP pathway. Copyright 1999 Harcourt Brace & Co. Ltd.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10657483 DOI: 10.1054/npep.1999.0008
Source DB: PubMed Journal: Neuropeptides ISSN: 0143-4179 Impact factor: 3.286